Orgenesis has agreed up to $50 million investment from Metalmark Capital in its US-based point of care services subsidiary, Morgenesis. The investment will consist of an upfront investment of $30 million and two future investments of $10 million each, subject to the achievement of certain milestones. Morgenesis will use the investment to develop and expand […]
